{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:30:16Z","timestamp":1778920216893,"version":"3.51.4"},"reference-count":49,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/ijo.2017.4105","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T07:50:28Z","timestamp":1503993028000},"page":"1291-1299","source":"Crossref","is-referenced-by-count":10,"title":["Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo"],"prefix":"10.3892","volume":"51","author":[{"given":"Xiaoni","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianji","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boxin","family":"Kou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyin","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjin","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"key20180107180354_b1-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2016.06.007","article-title":"Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biology","volume":"105","author":"Lamarca","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180107180354_b2-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11864-016-0415-3","article-title":"Advanced hepatocellular cancer: The currentstate of future research","volume":"17","author":"Connell","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"key20180107180354_b3-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.suronc.2016.03.002","article-title":"Hepatocellular carcinoma: From diagnosis to treatment","volume":"25","author":"Grandhi","year":"2016","journal-title":"Surg Oncol"},{"key":"key20180107180354_b4-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/CAD.0000000000000371","article-title":"Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma","volume":"27","author":"Zhao","year":"2016","journal-title":"Anticancer Drugs"},{"key":"key20180107180354_b5-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/cncr.30077","article-title":"Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer","volume":"122","author":"Vijayvergia","year":"2016","journal-title":"Cancer"},{"key":"key20180107180354_b6-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3892\/or.2015.4488","article-title":"Expression of DNA double-strand break repair proteins predicts the response and prognosis of colorectal cancer patients undergoing oxaliplatin-based chemotherapy","volume":"35","author":"Ihara","year":"2016","journal-title":"Oncol Rep"},{"key":"key20180107180354_b7-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/CAD.0000000000000371","article-title":"Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma","volume":"27","author":"Zhao","year":"2016","journal-title":"Anticancer Drugs"},{"key":"key20180107180354_b8-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.3748\/wjg.v21.i36.10443","article-title":"Chemoembolization alone vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients","volume":"21","author":"Gao","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20180107180354_b9-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"e4993","DOI":"10.1097\/MD.0000000000004993","article-title":"Efficacy and safety of the oxaliplatin-based chemotherapy in the treatment of advanced primary hepatocellular carcinoma: A meta-analysis of prospective studies","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key20180107180354_b10-ijo-51-04-1291","first-page":"1613","article-title":"Synergistic gastric cancer inhibition by chemogenetherapy with recombinant human adenovirus p53 and epirubicin: An in vitro and in vivo study","volume":"24","author":"Xie","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180107180354_b11-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/COC.0b013e3181fe4688","article-title":"Clinical therapeutic effect and biological monitoring of p53 gene in advanced hepatocellular carcinoma","volume":"37","author":"Chen","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"key20180107180354_b12-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/cgt.2010.40","article-title":"A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma","volume":"17","author":"Sangro","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"key20180107180354_b13-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.febslet.2005.01.069","article-title":"Downregulated mRNA expression of ASPP and the hypermethylation of the 5\u2032-untranslated region in cancer cell lines retaining wild-type p53","volume":"579","author":"Liu","year":"2005","journal-title":"FEBS Lett"},{"key":"key20180107180354_b14-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0014-5793(99)01726-3","article-title":"Aberrant overexpression of 53BP2 mRNA in lung cancer cell lines","volume":"465","author":"Mori","year":"2000","journal-title":"FEBS Lett"},{"key":"key20180107180354_b15-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000319692","article-title":"Expression pattern of the ASPP family members in endometrial endometrioid adenocarcinoma","volume":"33","author":"Liu","year":"2010","journal-title":"Onkologie"},{"key":"key20180107180354_b16-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/carcin\/bgt161","article-title":"Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation","volume":"34","author":"Mak","year":"2013","journal-title":"Carcinogenesis"},{"key":"key20180107180354_b17-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"e80193","DOI":"10.1371\/journal.pone.0080193","article-title":"Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure","volume":"8","author":"Schittenhelm","year":"2013","journal-title":"PLoS One"},{"key":"key20180107180354_b18-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1517\/14712598.2015.990882","article-title":"Key points of basic theories and clinical practice in rAd-p53 (Gendicine\u2122) gene therapy for solid malignant tumors","volume":"15","author":"Li","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"key20180107180354_b19-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2147\/OTT.S50483","article-title":"Clinical utility of recombinant adenoviral human p53 gene therapy: Current perspectives","volume":"7","author":"Chen","year":"2014","journal-title":"Onco Targets Ther"},{"key":"key20180107180354_b20-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/jcmm.12435","article-title":"ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy","volume":"19","author":"Shi","year":"2015","journal-title":"J Cell Mol Med"},{"key":"key20180107180354_b21-ijo-51-04-1291","first-page":"885","article-title":"Quality control of human ASPP2 recombinant adenovirus, 2016","volume":"32","author":"Wang","year":"2016","journal-title":"Zhongguo Yao Li Xue Tong Bao"},{"key":"key20180107180354_b22-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2052-8426-2-27","article-title":"Gene therapy for cancer: Present status and future perspective","volume":"2","author":"Amer","year":"2014","journal-title":"Mol Cell Ther"},{"key":"key20180107180354_b23-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nbt.1769","article-title":"Gene therapy finds its niche","volume":"29","author":"Sheridan","year":"2011","journal-title":"Nat Biotechnol"},{"key":"key20180107180354_b24-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1517\/14712598.2013.845662","article-title":"Advances in adenovirus-mediated p53 cancer gene therapy","volume":"13","author":"Tazawa","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"key20180107180354_b25-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ymthe.2004.07.021","article-title":"A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting","volume":"10","author":"Chiocca","year":"2004","journal-title":"Mol Ther"},{"key":"key20180107180354_b26-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"key":"key20180107180354_b27-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.2009.25.0597","article-title":"Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer","volume":"28","author":"Kantoff","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107180354_b28-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2217\/fon.10.134","article-title":"Sitimagene ceradenovec: A gene-based drug for the treatment of operable high-grade glioma","volume":"6","author":"van Putten","year":"2010","journal-title":"Future Oncol"},{"key":"key20180107180354_b29-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"e0159636","DOI":"10.1371\/journal.pone.0159636","article-title":"Immunohistochemical determination of p53 protein overexpression for predicting p53 gene mutations in hepatocellular carcinoma: A meta-analysis","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"key20180107180354_b30-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.ejca.2012.03.001","article-title":"Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: Evidence from a systematic review and meta-analysis","volume":"48","author":"Liu","year":"2012","journal-title":"Eur J Cancer"},{"key":"key20180107180354_b31-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/liv.12460","article-title":"The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China: Role of chronic hepatitis B virus infection and aflatoxin B1 exposure","volume":"35","author":"Qi","year":"2015","journal-title":"Liver Int"},{"key":"key20180107180354_b32-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0014-4827(81)90009-4","article-title":"Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation","volume":"136","author":"Bravo","year":"1981","journal-title":"Exp Cell Res"},{"key":"key20180107180354_b33-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/OTT.S126551","article-title":"Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: A systematic review and meta-analysis","volume":"10","author":"Yin","year":"2017","journal-title":"Onco Targets Ther"},{"key":"key20180107180354_b34-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1007\/s13277-015-4582-9","article-title":"The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma","volume":"37","author":"Ma","year":"2016","journal-title":"Tumour Biol"},{"key":"key20180107180354_b35-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.5858\/arpa.2012-0153-LE","article-title":"CD31 immunohistochemical staining in Kaposi Sarcoma","volume":"136","author":"Pantanowitz","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107180354_b36-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1590\/0001-3765201620160127","article-title":"The complex link between apoptosis and autophagy: A promising new role for RB","volume":"88","author":"Delou","year":"2016","journal-title":"An Acad Bras Cienc"},{"key":"key20180107180354_b37-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"502676","DOI":"10.1155\/2014\/502676","article-title":"The impact of autophagy on cell death modalities","volume":"2014","author":"Ryter","year":"2014","journal-title":"Int J Cell Biol"},{"key":"key20180107180354_b38-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1155\/2013\/102735","article-title":"Role of the crosstalk between autophagy and apoptosis in cancer, 2013","volume":"2013","author":"Su","year":"2013","journal-title":"J Oncol"},{"key":"key20180107180354_b39-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrm3735","article-title":"Self-consumption: The interplay of autophagy and apoptosis","volume":"15","author":"Mari\u00f1o","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107180354_b40-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"key20180107180354_b41-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3892\/ol.2016.5110","article-title":"The Ras\/Raf\/MEK\/ERK signaling pathway and its role in the occurrence and development of HCC","volume":"12","author":"Li","year":"2016","journal-title":"Oncol Lett"},{"key":"key20180107180354_b42-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","article-title":"Growing roles for the mTOR pathway","volume":"17","author":"Sarbassov","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"key20180107180354_b43-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.cellsig.2007.01.028","article-title":"Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K.MAPK and PKC sign aling pathways in human ovarian cancer cells, 2007","volume":"19","author":"Cao","year":"2007","journal-title":"Cel Signal"},{"key":"key20180107180354_b44-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.4161\/cbt.6.12.4976","article-title":"PDGF BB induces VEGF secretion in ovarian cancer","volume":"6","author":"Matei","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"key20180107180354_b45-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1158\/0008-5472.CAN-05-4340","article-title":"Ionizing radiation enhances matrix metal-loproteinase-2 secretion and invasion of glioma cells through Src\/epidermal growth factor receptor-mediated p38\/Akt and phosphatidylinositol 3-kinase\/Akt signaling pathways","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107180354_b46-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"103830","DOI":"10.1155\/2013\/103830","article-title":"Enhanced antitumor activity with combining effect of mTOR inhibition and microtubule stabilization in hepatocellular carcinoma","volume":"2013","author":"Zhou","year":"2013","journal-title":"Int J Hepatol"},{"key":"key20180107180354_b47-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.oraloncology.2015.03.004","article-title":"Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer","volume":"51","author":"Mali","year":"2015","journal-title":"Oral Oncol"},{"issue":"Suppl 2","key":"key20180107180354_b48-ijo-51-04-1291","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.4103\/0973-1482.119100","article-title":"Signal transducers and activators of transcription 3 function in lung cancer","volume":"9","author":"Li","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"key20180107180354_b49-ijo-51-04-1291","first-page":"46","article-title":"Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma","volume":"1835","author":"Subramaniam","year":"2013","journal-title":"Biochim Biophys Acta"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T21:47:42Z","timestamp":1570052862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2017.4105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,29]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/ijo.2017.4105"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2017.4105","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,29]]}}}